플러스100%마이너스

  • 화면크기
통합검색

한의약융합데이터센터


근거중심한의약 DB

Home > 한의약융합데이터센터 > 근거중심한의약 DB
Title

Xiaochaihu Tang for treatment of chronic hepatitis B: a systematic review of randomized trials.

Authors

Qin XK, Li P, Han M, Liu JP.

Journal

Zhong Xi Yi Jie He Xue Bao.

Year

2010

Vol (Issue)

8(4)

Page

312-320.

doi

10.3736/jcim20100403.

PMID

20388470

Url

http://www.ncbi.nlm.nih.gov/pubmed/20388470

MeSH

Drugs, Chinese Herbal*
Hepatitis B, Chronic/drug therapy*
Humans
Phytotherapy*
Randomized Controlled Trials as Topic
Treatment Outcome

Keywords

Xiaochaihu Tang; chronic hepatitis B; systematic review; randomized controlled trials

한글 키워드

소시호탕; 만성 B형 간염; 체계적 문헌고찰; 무작위배정 비교임상시험

KMCRIC
Summary & Commentary

KMCRIC 비평 보기 +

Korean Study

Abstract

BACKGROUND:
Xiaochaihu Tang was a compound traditional Chinese herbal medicine recorded in ancient Chinese medical book Shanghanlun, and has been widely used for chronic liver diseases especially in Japan.

OBJECTIVE:
To assess the beneficial effects and safety of Xiaochaihu Tang, for chronic hepatitis B (CHB).

SEARCH STRATEGY:
Electronic and manual searches were conducted and the search ended in November 2009.

INCLUSION CRITERIA:
We included randomized clinical trials testing Xiaochaihu Tang against placebo, non-specific treatment, antivirals, or combined with antivirals against antivirals alone.

DATA EXTRACTION AND ANALYSIS:
Selection of trials for inclusion, assessment of methodological quality by Jadad score, data extraction and data syntheses were conducted according to the Cochrane Hepato-Biliary Group methods.

RESULTS:
Sixteen randomized trials (involving 1 601 CHB patients) with various methodological quality were included. One trial published in English had good quality, while other trials published in Chinese were of poor quality. The pooled results showed that Xiaochaihu Tang combined with antiviral drugs was more effective in serum loss of hepatitis B viral markers and in improving liver function compared with antiviral drugs alone. Xiaochaihu Tang was not different from placebo in terms of viral clearance or improving liver function. However, Xiaochaihu Tang was superior to non-specific treatment in liver function improvement. There were no adverse effects reported in the trials regarding Xiaochaihu Tang, but adverse effects were reported in patients treated by interferon, and severe adverse effects occurred in few cases.

CONCLUSION:
Xiaochaihu Tang in this review appears to be effective in improving liver function and clearance of serum hepatitis B viral markers in patients with chronic hepatitis B. However, due to poor methodological quality in the majority of included trials the potential benefits need to be confirmed in rigorous clinical trials following international standards.

국문초록

Language

중국어

첨부파일